Supplies for Ghana's Food and Drugs Authority - Molecular Biology Laboratory
The procurement will include supply, delivery, installation and after-sales services including training and maintenance of equipment to support the primary function of the Food and Drugs Authority's (Ghana) molecular biology laboratory .
What the buyer needs
- The procurement will include supply, delivery, installation and after-sales services including training and maintenance of equipment to support the primary function of the Food and Drugs Authority's (Ghana) molecular…
- The primary purpose of the molecular biology lab is to support lot release functions of the FDA and to expand the scope of laboratory testing to include vaccines and biological products.
- The facility is intended to equip the FDA to achieve World Health Organization (WHO) Maturity Level 4 as a vaccine producing country.
Procurement signals
- Procedure: EC-INTPA/ACC/2025/EA-OP/0054-PIN
- Procedure type: Source procedure code 47396222
- Contract type: Supply contract (31095499)
- Submission method: Electronic submission
- Published: 31 Mar 2025
Procurement categories
CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.
Programme and geography
Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.
Source-backed details
Original identifiers and classification fields from the EU tender source.
- EC-INTPA/ACC/2025/EA-OP/0054-PIN
- 83e53d0c-64dd-4b61-b325-b88c8aef8e15-PIN
- Source procedure code 47396222
- Supply contract (31095499)
- 47352462
- Africa/Accra
- 17 Jun 2026, 21:04 UTC
Full official description
The procurement will include supply, delivery, installation and after-sales services including training and maintenance of equipment to support the primary function of the Food and Drugs Authority's (Ghana) molecular biology laboratory . The primary purpose of the molecular biology lab is to support lot release functions of the FDA and to expand the scope of laboratory testing to include vaccines and biological products. The facility is intended to equip the FDA to achieve World Health Organization (WHO) Maturity Level 4 as a vaccine producing country.